This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

UPDATE: Women Will Soon Have Access To More Cost-Effective, Environmentally Friendly Alternative To Feminine Hygiene Products Such As Sanitary Napkins And Tampons

SAN DIEGO, Nov. 29, 2012 /PR Newswire/ -- FemCap, Inc. announces The FemmyCycle®, a novel product granted clearance by The U.S. Food and Drug Administration on November 16, 2012. An eco-friendly alternative to sanitary napkins and tampons, The FemmyCycle® enhances the quality of women's lives by helping them better manage their menstrual periods.

FemmyCycle® creator Dr Alfred Shihata is familiar with developing innovative feminine products. His FDA-approved FemCap® is one of the few hormone-free, woman-controlled contraceptive methods available.

"When I developed The FemCap®, my goal was to provide women with a safe and effective hormone-free birth control device. The motivation behind The FemmyCycle® was much the sameā€”to provide a safer, more convenient alternative to pads and tampons at a lower economic and environmental cost," Dr. Shihata said.

The FemmyCycle's® unique, non-spill-design collects and holds menstrual flow for up to 12 hours. Collecting menstrual flow rather than absorbing it eliminates the risk of toxic shock syndrome associated with tampons. Additionally, women using the device reported an absence of odor and leaks as the device keeps menstrual fluid away from vaginal walls and vulva and unexposed to air.

The FemmyCycle® is safe for up to 12 hours of use and can be worn during exercise and other daily activities, so it is ideal for athletes and working women. It is a reusable device made of soft, medical grade silicone and lasts for a period of a year or more, making it an environmentally friendly alternative to tampons and pads. The FemmyCycle® is cost-effective at $39.95 per twin pack and will be available online and in stores on January 14, 2013.

FemCap, Inc. is a Del Mar, California-based company founded by Dr Alfred Shihata, developer of the FDA-approved FemCap® contraceptive device and the FemmyCycle® menstrual collection cup. www.femcap.com

Contact: Dr Alfred ShihataFemCap, Inc.14058 Mira Montana Drive Del Mar, CA 92014Phone: 858-481-8837FAX: 858-792-2624email: femcap@yahoo.com   www.femmycycle.com  FemmyCycle FDA 510(k) Number: 121857

SOURCE FemCap, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs